impact innovation
Making the hope of early detection, a reality.
breakthrough products designed for massive scale across B2B & B2C markets.
iBreastExam (B2B)
Award-winning, patent-pending, radiation-free, ultra-portable wireless device, usable by lay health-workers to identify and document small, non-palpable lumps, quickly and easily, at the point-of-care.
FDA cleared. In commercialization.
cervAIcal (B2B)
AI enabled mobile colposcope
for cervical cancer screening. CervAIcal is a high-quality, wireless universal cervical examination assistant that goes where the patients are. Ongoing Pilots.
Selfi (B2C)
World's first, at home
breast health monitoring
device / app / platform
built with iBreastExam technology
Commercial launch expected in 2022
Facts & Figures
Some statistics from our journey thus far. Read more...
2 million+
breast exams enabled
250+
Cancers Detected
10
Markets Entered
$1.7M+
Grant Awards
$5.85M
Capital Raised
15+
Awards
Contact Us
You + Us = Awesome
UE LifeSciences Inc. Copyright © 2021 | Terms & Conditions